Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study
- Sponsor
- manxiaxia
- Study ID
- NCT07572409
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- CPLN resection — PROCEDUREDiaphragmatic angle lymph node dissection
Study Details
The aim of this study is to investigate the efficacy and safety of enucleation of enlarged CPLNs in patients with advanced ovarian cancer.
Key Dates
- First listed
- May 7, 2026
- Start date
- Jul 1, 2026
- Status verified
- Apr 2026
- Primary completion
- Jul 1, 2030
- Completion
- Jul 1, 2030
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: Study population
Primary Outcome Measure
RFS [ Time Frame: experimental group 17.2 month ]
Central Contacts
- Li XIAOSEN+8618343116682
Find similar trials
Related Studies
- Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruiting · Northwestern University · Chicago, Illinois
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenRecruiting · M.D. Anderson Cancer Center · Miami, Florida
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood SamplesRecruiting · Stanford University · Stanford, California
- Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland